Prelude Capital Management’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$75.2K Sell
19,673
-125,046
-86% -$605K 0.01% 1142
2026
Q1
$767K Buy
144,719
+70,498
+95% +$435K 0.06% 360
2025
Q4
$573K Buy
+74,221
New +$661K 0.04% 479
2025
Q3
Sell
-180,400
Closed -$749K 1407
2025
Q2
$749K Buy
+180,400
New +$1.13M 0.07% 333
2017
Q4
Sell
-375
Closed -$21K 1748
2017
Q3
$21K Buy
375
+125
+50% +$5.9K ﹤0.01% 1313
2017
Q2
$7K Sell
250
-2,167
-90% -$55.1K ﹤0.01% 1444
2017
Q1
$60K Buy
2,417
+784
+48% +$12.4K 0.01% 921
2016
Q4
$22K Buy
1,633
+1,025
+169% +$15.3K ﹤0.01% 1299
2016
Q3
$10K Buy
+608
New +$9.79K ﹤0.01% 1433

Other funds holding VSTM

Prelude Capital Management's VSTM Position: Q2 2026 in Review

Prelude Capital Management reduced its Verastem (VSTM) stake by 86% in Q2 2026, selling an estimated $605K and leaving 19,673 shares worth $75.2K. The position accounts for 0.01% of the portfolio, ranked #1142.

Prelude Capital Management first reported a position in VSTM in Q3 2016 and has held it in 9 quarters since. The position peaked at $767K in Q1 2026. 156 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • Prelude Capital Management held 19,673 shares of Verastem worth $75.2K as of Q2 2026.
  • Prelude Capital Management sold 125,046 Verastem shares in Q2 2026, an estimated $605K.
  • Verastem made up 0.01% of Prelude Capital Management's portfolio in Q2 2026, its #1142 holding.
  • Prelude Capital Management first reported a position in Verastem in Q3 2016 and has held it in 9 quarters since.
  • Prelude Capital Management's Verastem position peaked at $767K in Q1 2026.
  • 156 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.